Loading…
Palatin Technologies, Inc. is projected to decline to $7.70 by 2027, a -6% move from its current price of $8.23. PTN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $7.91 | $8.23 | $8.56 | -0.02% |
| Aug 6 | $7.78 | $8.23 | $8.69 | -0.05% |
| Aug 7 | $7.69 | $8.22 | $8.80 | -0.07% |
| Aug 8 | $7.60 | $8.22 | $8.89 | -0.10% |
| Aug 9 | $7.53 | $8.22 | $8.97 | -0.12% |
| Aug 10 | $7.47 | $8.22 | $9.04 | -0.14% |
| Aug 11 | $7.41 | $8.22 | $9.11 | -0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.41 | $8.22 | $9.11 | -0.17% |
| Week 2 | $7.09 | $8.20 | $9.49 | -0.34% |
| Week 3 | $6.85 | $8.19 | $9.79 | -0.51% |
| Week 4 | $6.65 | $8.17 | $10.05 | -0.67% |
| Week 5 | $6.48 | $8.16 | $10.28 | -0.84% |
| Week 6 | $6.33 | $8.15 | $10.49 | -1.01% |
| Week 7 | $6.19 | $8.13 | $10.69 | -1.18% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Palatin Technologies, Inc. is a biopharmaceutical company that develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.
The company’s pipeline includes an oral small molecule PL7737 MC4R agonist in preclinical studies, long-acting peptide MC4R agonists, and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy.
Palatin also develops PL9643 for dry eye disease and anti-inflammatory ocular indications, and oral PL8177 for the treatment of inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Palatin Technologies, Inc. (PTN) trades in the Healthcare sector. The current price is $8.15 per share and the market capitalization is $14.5M, with a rank of 4799.
The stock shows a bearish tilt in the near term with RSI14 at 30, a 50-day moving average of $12.49 and a 200-day moving average of $15.75. It sits at a support level of $8.15 and faces resistance near $14.20. The 30-day trading range runs from $6.06 to $10.97, and annualized volatility is 90%.
Looking ahead, the multi-year forecast spans from a near-term flat to modestly volatile path through 2026-2035, then broadens into stronger upside in the 2040-2050 horizon, with average prices and ROI ranging from near the current level to sizable long-term gains.
A major floor 39.7% below — a decisive break under it would weaken the trend.
The nearest floor, 6.7% below — buyers have tended to step in here.
The nearest ceiling, 43.0% above — a clean break opens room to run.
A major ceiling 173.4% above — clearing it would confirm fresh momentum.
Key PTN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PTN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.82 | Buy | $7.85 | Buy |
| MA 10 | $8.01 | Buy | $8.12 | Buy |
| MA 20 | $8.88 | Sell | $8.88 | Sell |
| MA 50 | $11.30 | Sell | $11.25 | Sell |
| MA 100 | $15.58 | Sell | $13.55 | Sell |
| MA 200 | $15.76 | Sell | $16.00 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.17 | Neutral |
| Stoch RSI (14) | 51.93 | Neutral |
| CCI (20) | -85.74 | Neutral |
| Williams %R (14) | -98.58 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | -13.48 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 1.42 | Buy |
| TRIX (15) | -1.56 | Sell |
| Awesome (5,34) | -2.12 | Sell |
| Ultimate (7,14,28) | 33.00 | Neutral |
| Momentum (10) | -1.39 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 7.78 | Buy |
| ADX (14) | 34.44 | Sell |
| ATR (14) | 0.38 | Info |
The 30-day technical picture points to a bearish sentiment, with RSI at 30 and near-term momentum tilted lower.
The stock trades with a $8.15 support and faces a $14.20 resistance, while the 50-day moving average sits at $12.49 and the 200-day moving average at $15.75. The 30-day range is $6.06–$10.97, highlighting recent price volatility.
Overall, volatility is high, with an annualized volatility of 90%, suggesting significant risk and potential for quick swings in price during the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.68 | $8.23 | $10.60 | 0% | Neutral | |
| $5.91 | $7.70 | $10.75 | -6% | Neutral | |
| $5.97 | $8.12 | $11.93 | -1% | Neutral | |
| $5.10 | $7.19 | $10.98 | -13% | Neutral | |
| $4.86 | $7.07 | $11.15 | -14% | Neutral | |
| $5.77 | $8.64 | $14.01 | +5% | Neutral | |
| $6.44 | $9.90 | $16.48 | +20% | Bullish | |
| $6.48 | $10.24 | $17.42 | +24% | Bullish | |
| $5.81 | $9.40 | $16.33 | +14% | Neutral | |
| $5.46 | $9.06 | $16.03 | +10% | Neutral | |
| $7.02 | $13.01 | $24.90 | +58% | Bullish | |
| $9.66 | $21.46 | $45.97 | +161% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $7.68 | $8.23 | $10.26 | +0.00% |
| September 2026 | $6.83 | $8.18 | $10.14 | -0.61% |
| October 2026 | $6.66 | $8.05 | $10.13 | -1.58% |
| November 2026 | $6.81 | $8.30 | $10.57 | +3.08% |
| December 2026 | $6.71 | $8.23 | $10.60 | -0.78% |
Click any year to see its month-by-month PTN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PTN is projected to trade between $7.68 and $10.60, averaging $8.23 — a potential gain of 0% from today's $8.23. A consolidation phase looks the most probable path here.
Palatin Technologies, Inc.'s 2027 outlook centres on $7.70, within a $5.91 to $10.75 range. That is -6% versus the projected 2026 average. That marks a -6% change versus current levels. Price action looks broadly range-bound.
By 2028, PTN could reach as high as $11.93, with a base case around $8.12 and support toward $5.97 — roughly -1% from $8.23. A consolidation phase looks the most probable path here.
Expect PTN to range from $5.10 to $10.98 through 2029. The $7.19 average target implies a -13% move from current prices. That is -11% versus the projected 2028 average. Price action looks broadly range-bound.
The PTN price prediction for 2030 points to an average of $7.07 (low $4.86, high $11.15) — a potential decline of -14% on today's $8.23. A consolidation phase looks the most probable path here.
In 2031, PTN is projected to trade between $5.77 and $14.01, averaging $8.64 — a potential gain of +5% from today's $8.23. That is up +22% on the projected 2030 average. Price action looks broadly range-bound.
Palatin Technologies, Inc.'s 2032 outlook centres on $9.90, within a $6.44 to $16.48 range. That is up +15% on the projected 2031 average. That marks a +20% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PTN could reach as high as $17.42, with a base case around $10.24 and support toward $6.48 — roughly +24% from $8.23. Momentum favours further upside here.
Expect PTN to range from $5.81 to $16.33 through 2034. The $9.40 average target implies a +14% move from current prices. That is -8% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The PTN price prediction for 2035 points to an average of $9.06 (low $5.46, high $16.03) — a potential gain of +10% on today's $8.23. Price action looks broadly range-bound.
In 2040, PTN is projected to trade between $7.02 and $24.90, averaging $13.01 — a potential gain of +58% from today's $8.23. That is up +44% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Palatin Technologies, Inc.'s 2050 outlook centres on $21.46, within a $9.66 to $45.97 range. That is up +65% on the projected 2040 average. That marks a +161% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PTN today (≈ 121.506683 PTN) could be worth
$2,607.56
+$1,607.56 (+161%) by 2050 · US Dollar
Based on the average projected PTN price of $21.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PTNwould be worth at today's price.
$1,000 invested in PTN on Jul 31, 2025 (≈ 95.238095 PTN) would be worth
$783.81
-$216.19 (-21.6%) today · 0.78× · US Dollar
Based on a PTN entry price of $10.5 vs. today's $8.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.71 | $1,067.44 | +6.7% |
| 1 month ago | $10.33 | $796.71 | -20.3% |
| 3 months ago | $20.23 | $406.82 | -59.3% |
| 6 months ago | $17.25 | $477.1 | -52.3% |
| 1 year ago | $10.5 | $783.81 | -21.6% |
| All time (5.0y) ago | $625 | $13.17 | -98.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PTN forecast.
Our base-case forecast reaches $16.00 around 2050.
Implied market cap at $16.00: $28.47M
The year-by-year forecast shows a mixed near-term path and a stronger long-run upside.
In 2030 the average price is projected at $6.71 with a min of $4.42 and a max of $11.03, reflecting a -17.6% ROI and a bearish sentiment. The forecast turns more neutral in 2031 with an average of $8.72 and a positive 7% ROI, followed by further gains in 2032 ($9.68 avg) and 2033 ($10.14 avg) with bullish momentum building by 2033 (24.4% ROI).
The long horizon shows notable upside: 2040 is forecast with an average of $12.90 and a max of $26.21, delivering a 58.3% ROI and a bullish stance. By 2050, the average price is $20.69 with a max of $47.47 and a strong 153.9% ROI, continuing the bullish outlook.
Tap a question to reveal the answer.
In 2030, PTN’s avg price is $6.71 with a min of $4.42 and a max of $11.03, for a ROI of -17.6% and a bearish sentiment.
The forecast shows mixed signals: near term includes a 0% ROI in 2026 and negative ROIs in 2027-2030, with a shift to positive returns beginning in 2031 and stronger gains in 2040 and 2050, culminating in a 153.9% ROI by 2050. These are estimates, not guarantees.
Yes, the forecast shows higher-end outcomes such as a max of $18.11 in 2033, $16.86 in 2032, $26.21 in 2040, and $47.47 in 2050, indicating potential to exceed $15 and reach higher targets in the longer term.
Current price is $8.15 and market cap is $14.5M.
The 30-day range runs from $6.06 to $10.97.
Palatin Technologies, Inc. Community Discussion
0Share your Palatin Technologies, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.